axitinib,al-101,avelumab,sunitinib
merck,pfizer,ayala pharma
['avelumab', 'sunitinib', 'rcc,(-irccs),(-srcc),(-urcc)', 'al 101', 'renal,(-adrenal)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'javelin,renal,101', 'marker ']
crp as a predictive marker for outcomes w/ avel + axi in poor-risk arcc: javelin renal 101 #gu23 pfs &amp; os favored avel + axi over sun in pts w/ 3 or 4-6 imdc rfs pts w/ prolonged pfs &amp; os - 3 imdc rfs: crp low @ baseline &amp; @ 24 mo - 4-6 imdc 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday